Hillel Galitzer

Title: Hillel Galitzer: Innovator in Pharmaceutical Compositions

Introduction

Hillel Galitzer is a notable inventor based in Yad Binyamin, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for oral administration of active agents. With a total of 3 patents, his work focuses on enhancing the efficacy of therapeutic agents through innovative compositions.

Latest Patents

Galitzer's latest patents include formulations that combine therapeutically active agents with absorption enhancers such as NAC, NAD, 5-CNAC, 4-MOAC, and 4-CNAB. These pharmaceutical compositions are designed for the treatment of various conditions and allow for the concomitant oral administration of multiple unit dosage forms. Another significant patent involves a composition that includes SNAC and at least one antacid compound, aimed at improving the oral administration of therapeutic agents. This innovative approach not only enhances absorption but also provides a protective layer for the active ingredients.

Career Highlights

Hillel Galitzer is currently associated with Entera Bio Ltd., where he continues to push the boundaries of pharmaceutical innovation. His work has been instrumental in developing new methods and uses for oral administration of active agents, contributing to advancements in the treatment of various medical conditions.

Collaborations

Galitzer collaborates with esteemed colleagues such as Gregory Burshtein and Ariel Rothner, further enriching the research and development environment at Entera Bio Ltd. Their combined expertise fosters a culture of innovation and excellence in pharmaceutical research.

Conclusion

Hillel Galitzer's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a key inventor in the industry. His work continues to pave the way for advancements in therapeutic compositions, ultimately benefiting patients worldwide.